McKesson (NYSE:MCK) Issues FY 2026 Earnings Guidance

McKesson (NYSE:MCK) updated its FY 2026 earnings guidance on Sunday. The company provided earnings per share guidance of 38.050-38.550 for the period, compared to the consensus earnings per share estimate of 37.370. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on MCK. Wells Fargo & Company boosted their target price on shares of McKesson from $772.00 to $816.00 and gave the company an “equal weight” rating in a research note on Wednesday, September 24th. Bank of America boosted their price objective on shares of McKesson from $800.00 to $850.00 and gave the company a “buy” rating in a research report on Wednesday, September 24th. Wall Street Zen raised shares of McKesson from a “hold” rating to a “buy” rating in a report on Sunday, September 28th. Mizuho lifted their target price on McKesson from $750.00 to $770.00 and gave the company a “neutral” rating in a research note on Wednesday, September 24th. Finally, TD Cowen increased their price target on McKesson from $830.00 to $864.00 and gave the stock a “buy” rating in a research report on Wednesday, September 24th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $829.08.

McKesson Trading Down 2.7%

NYSE MCK opened at $738.00 on Friday. The company has a 50-day moving average price of $702.60 and a two-hundred day moving average price of $703.23. McKesson has a 52 week low of $480.39 and a 52 week high of $776.14. The stock has a market cap of $91.79 billion, a price-to-earnings ratio of 29.43, a price-to-earnings-growth ratio of 1.32 and a beta of 0.52.

McKesson (NYSE:MCK) last released its quarterly earnings results on Wednesday, August 6th. The company reported $8.26 earnings per share for the quarter, missing analysts’ consensus estimates of $8.33 by ($0.07). McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business had revenue of $97.83 billion for the quarter, compared to the consensus estimate of $95.93 billion. During the same period last year, the firm posted $7.88 EPS. The business’s quarterly revenue was up 23.4% on a year-over-year basis. As a group, equities research analysts expect that McKesson will post 32.77 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd were given a dividend of $0.82 per share. This is a boost from McKesson’s previous quarterly dividend of $0.71. The ex-dividend date was Tuesday, September 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is presently 13.08%.

Insiders Place Their Bets

In related news, CEO Brian S. Tyler sold 19,371 shares of the stock in a transaction dated Friday, July 11th. The shares were sold at an average price of $708.09, for a total value of $13,716,411.39. Following the completion of the transaction, the chief executive officer owned 27,872 shares in the company, valued at $19,735,884.48. This represents a 41.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm’s stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the transaction, the chief accounting officer directly owned 657 shares in the company, valued at approximately $436,031.19. The trade was a 33.37% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,560 shares of company stock worth $30,438,602 over the last three months. Corporate insiders own 0.08% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Ameriprise Financial Inc. raised its holdings in McKesson by 2.8% during the second quarter. Ameriprise Financial Inc. now owns 427,700 shares of the company’s stock worth $313,001,000 after purchasing an additional 11,688 shares in the last quarter. Raymond James Financial Inc. increased its position in shares of McKesson by 15.3% during the 2nd quarter. Raymond James Financial Inc. now owns 289,278 shares of the company’s stock valued at $211,977,000 after purchasing an additional 38,457 shares during the period. Man Group plc raised its stake in shares of McKesson by 40.1% in the 2nd quarter. Man Group plc now owns 239,324 shares of the company’s stock worth $175,372,000 after buying an additional 68,454 shares in the last quarter. Canada Pension Plan Investment Board lifted its holdings in shares of McKesson by 443.0% in the second quarter. Canada Pension Plan Investment Board now owns 105,613 shares of the company’s stock valued at $77,391,000 after buying an additional 86,162 shares during the period. Finally, Treasurer of the State of North Carolina boosted its stake in McKesson by 0.9% during the second quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock valued at $42,958,000 after buying an additional 508 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.